Madison Avenue Partners, LP - Significant Ownership

Signature - Title
Chris Carroll - CCO
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Madison Avenue Partners, LP.

Significant Ownership of Madison Avenue Partners, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SAGE Sage Therapeutics, Inc. Common Stock, par value $0.0001 per share (the "Common Stock") 8% $36.4M 4.92M Madison Avenue International LP Mar 25, 2025
INDV Indivior PLC Ordinary shares, $0.50 nominal value per share (the "Ordinary Shares") 6% $72.6M 7.44M Madison Avenue International LP Mar 11, 2025
WLY John Wiley & Sons, Inc. Class A Common Stock, par value $1.00 per share (the "Common Stock") 4.95% $104M 2.23M Madison Avenue Partners, LP Dec 31, 2024
OVID Ovid Therapeutics Inc. Common Stock, par value $0.001 per share (the "Common Stock") 4% $1.77M 2.85M Madison Avenue Partners, LP Dec 31, 2024

Schedules 13D/G Reported by Madison Avenue Partners, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.